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In vivo, after antigenic stimulation, mice develop antibody responses repre- 
senting  all  five  major  immunoglobulin  classes  (1-5).  Evaluation  of  serum 
antibody responses to heterologous erythrocytes at the cellular level is possible 
with  the  hemolytic plaque technique  which  facilitates  the  screening  of large 
numbers of lymphoid cells for those cells releasing antibodies against  erythro- 
cyte antigens.  The technique  as described initially by Jerne et al.  (6,  7)  enu- 
merated  only cells releasing  high  hemolytic  efficiency, %,M  antibodies  (6-9). 
Modifications have permitted  enumeration  of those  cells releasing  antibodies 
of  other  immunoglobulin  classes  (10-12).  By  using  heterologous  anti-mouse 
globulins monospecific for each major immunoglobulin class, antibody-releasing 
cells from each class have been detected and the kinetics of their appearance 
after  immunization  have  been  described  (1,  2,  5).  7G  I  plaque-forming  cells 
(PFC)  usually are detected later and reach maximum numbers later than do 
7M PFC  (1,  2,  5). "),M PFC are thought to develop by rapid division of pre- 
cursor cells restricted  to production  of antibody of the 7M  class  (6,  13-17). 
The developmental pathway of ~,G PFC  has still not been precisely defined. 
These cells may arise by proliferation of specific precursors restricted to pro- 
duction of antibodies of a single immunoglobulin class (2,  18,  19),  or they may 
develop by conversion of cells from %,M to a  given class of 7G antibody syn- 
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thesis (20). •G  PFC may also develop by recruitment of potential antibody- 
producing cells restricted  to  immunoglobulin class without cell division (1). 
The cell suspension system for stimulation of antibody production to het- 
erologous erythrocytes by murine spleen cells in vitro, as developed by Mishell 
and Dutton (21), is ideally suited for investigation of these possibilities. Here, 
critical variables such as antigen presentation and interactions among required 
cell  types  can  be  more  precisely controlled and  the  essential events in the 
development  of  responses  representing  individual  immunoglobulin classes 
analyzed. However, in previous studies with this culture system, numerically 
significant primary 3'G PFC responses were not detected (22). 
The present studies were  initiated to investigate whether  this failure was 
the result of methodology and reagents or a  more fundamental failure of the 
culture system to support development of primary "FG and ~,A PFC responses. 
We now present a modification of the hemolytic plaque assay which has enabled 
us for the first time to directly enumerate PFC representing all the major im- 
munoglobulin classes in cultures of mouse spleen cells stimulated in vitro with 
heterologous erythrocytes. The culture conditions found to  support develop- 
ment of  these responses and the kinetics of appearance of PFC representing 
each  immunoglobulin class  will be  described.  The  analysis of  the  effects  of 
anti-erythrocyte antibody on primary 7M and ~/G PFC responses will illustrate 
some  of  the  fundamental differences in these  responses. 
Materials and Methods 
Animals.--C57BL/6N  and BALB/cAnN  male mice, 3-4 months  old, and New Zealand 
white male rabbits, 3-6 months old, obtained from the NIH Rodent and Rabbit Production 
Section were maintained on the appropriate Purina chow and water ad libitum.  Goats were 
maintained at the NIH Ungulate Division on a standard  goat diet. 
Erythrocyte Antigens and Anti-Erythrocyte Antisera.--Erythrocytes from one sheep (SRBC) 
and one horse (HRBC), maintained at the NIH Ungulate Division, were collected biweekly 
under sterile conditions into acid citrate-dextrose  solution. Erythrocytes  were washed by 
centrifugation three times with 40 volumes of sterile Hanks' balanced salt solution (HBSS) 
and resuspended in HBSS to 20 X  l0 s erythrocytes/ml  for immunization or for use in the 
hemolytic plaque assay; erythrocytes for stimulation of cultures were resuspended in HBSS to 
2.5 X  10  s erythrocytes/ml. 
Antisera against SRBC and HRBC were obtained from rabbits bled by cardiac puncture 
10 days after the last of three weekly intravenous injections of 5 ml of a suspension containing 
20 )< 108 RBC/ml. Sera were separated, decomplemented by heat  at 56°C for 30 min, steri- 
lized by passage through a prewashed 0.22 #  Millipore filter, and stored at --20°C in 1 ml 
portions. Hemagglutinin titers were 1/6000 to 1/8000 against  the  immunizing erythrocyte 
and less than 1/10 against nonimmunizing erythrocytes.  Antibody activity was resistant  to 
treatment with  0.1  M 2-mercaptoethanol  for  30  min  at  37°C. Antibody concentration 
is expressed as the  reciprocal of the titer in the  culture dish. For example, a serum with 
a titer of 1/8000 was diluted 1/1000 and 0.05 ml was added to a  1 ml culture giving a con- 
centration of 4 >( 10  -1. 
Preparation of Mydoma Proteins and Anti-Immunoglobulin  Sera.--Purifled  myeloma pro- 
teins were prepared  from ascitic fluid from BALB/cAnN mice bearing plasma cell tumors PIERCE~  ~OI-INSON~ GERSHON,  ASO~SKY  397 
adapted to the ascites form. Pools of urine from mice bearing myeloma tumor MOPC-104E 
were the source of  k-chain.  Immunogens for preparation  of polyvalent anti-3,G and  anti- 
3,2a -b 2b were purified from pools of hyperimmune sera from several inbred strains of mice. 
Immunogens were purified by preparative electrophoresis in a Geon-Pevikon resin block (23) 
followed by gel filtration through Sephadex-G-200  (22, 23).  Fc fragment was isolated from 
MOPC-31c  myeloma protein  after  papain  digestion  for  the preparation  of  anti-3,1 sera 
(24, 25). Antiglobulins used for development of 3"G and 3"A PFC were prepared in rabbits using 
the immunogens prepared as described above and listed in Table I. Anti-mouse D-chain anti- 
body was prepared in goats. 
TABLE I 
Biological Reagents 
Antiglobulin  Immunogen  Absorbed with* 
Goat anti-#  MOPC-104E  myeloma  pro- 
tein 
Rabbit anti-3,M  "  " 
Rabbit anti-3,G (polyvalent)  Slow electrophoretic fraction 
from hyperimmune serum 
Rabbit anti-3"2a+2b  "  " 
Rabbit anti-3'1  MOPC-3 lc myeloma protein 
Fc piece 
Myeloma protein 
MOPC-104E 
MPC-47, MOPC-70A, MOPC-31c 
LPC-1, RPC-5 
MPC:ll, MPC-37 
SPC-1, MPC-40 
k-chain  (MOPC-104E  uri- 
nary  protein) 
No absorption 
3,1  (MOPC-70A  myeloma 
protein) 
3,~b (MPC-37 myeloma pro- 
tein) 
Imrnunoglobulin  class 
7M 
3'1 
3"2b 
3"A 
* Germfree serum was used to absorb antibodies to serum proteins other than immuno- 
globulins. 
All separated rabbit and goat sera were decomplemented at 56°C for 30 min and absorbed 
twice with 1 ml each of washed, packed SRBC and HRBC/10 ml serum and once with 1 ml of 
washed, packed C57BL/6N spleen cells/10 ml serum. Initial specificity of the antiglobulins 
was tested by double diffusion in agar.  Required absorptions to achieve monospecific anti- 
globulins were performed using the purified myeloma proteins and germfree serum as indicated 
in Table I. After absorption, monospecific  antiglobulins had no detectable reaction with non- 
homologous myeloma proteins by agar diffusion.  Monospecific antiglobulins coupled to bromo- 
acetyl-cellulose (26) did  not  bind t25I-labeled  light chains or myeloma proteins of immuno- 
globulin classes other than the one against which the antigl0bulin was directed. 
Spleen  Cell  Cultures.--Spleen  cell suspensions  were prepared  under sterile conditions by 
gently teasing apart the spleens with forceps into cold HBSS; after residual tissue fragments 
had settled by gravity, the supernatant cell suspension  was separated and centrifuged for 10 
min at 600 g at 4°C. The sedimented cells were resuspended to the desired density, usually 
1  X  107 cells/ml,  in completely supplemented  Eagle's minimal essential medium  (MEM), 
monolayer type, with Hanks' salts  (21, 22, 27),  containing 10% fetal bovine serum (Reheis 398  IMMUNE  RESPONSES  IN  VITRO.  III 
Chemical Co., Kankakee,  II1., Lot E21505),  and  50 units  each/ml of penicillin and  myco- 
statin, and 50 #g/ml of streptomycin. Tissue culture media and supplements except sera were 
obtained from Microbiological Associates,  Inc., Bethesda, Md. 
The spleen cells in  1 ml volumes were incubated with or without erythrocyte antigens, 
usually 106-107/culture, in a water-saturated atmosphere of 7% 02, 10% CO~, and 83% N2 
at 37°C in a large alr-tight plastic box on a rocker platform oscillating at 31~ complete cycles/ 
rain.  Experimental groups were composed of three culture dishes which were supplemented 
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FIG. 1.  Schematic representation of the assay procedure for direct (3~M) PFC and indirect 
(3'G ~nd 3,A) PFC using the blocked 3'M PFC method. 
daily with 0.05 ml fetal bovine serum and 0.05 ml of a nutritional mixture prepared by supple- 
menting HBSS with 10 mg/ml dextrose and glutamine and amino acids in twice the concentra- 
tion as in completely supplemented MEM (22, 27). 
Hemolytic Plaque A ssay.--Cells from each experimental group were harvested by aspiration, 
pooled and sedimented by centrifugatiou. The supernatant culture fluid was discarded and the 
sedimented cells were resuspended in HBSS at dilutions expected to give 30-300 plaques/slide. 
The number of PFC was determined by the Jerne hemolytic plaque technique (6, 7),  modified 
for use with glass microscope slides (5, 21, 22) and illustrated in Fig. 1. 
For enumeration of direct or "yM PFC, agarose  (L'Industrie Biologique Francaise  S.A., 
Gennevilliers, France),  0.5%  in  tris(hydroxymethyl)aminomethane  (Tris)-buffered  Eagle's 
MEM without serum (Medium 327 from the NIH Media Unit), 0.40 ml; indicator erythro- 
cytes, 7.5%, 0.05 ml; and the culture cell suspension, 0.1 ml, were mixed at 44°C in 10 X  75 PIERCE, JOHNSON:  GERSHON, ASOFSKY  399 
mm glass tubes and poured  onto microscope slides  previously coated with 0.1% agarose in 
water. Duplicate slides, prepared from each group, were incubated for 1 hr at 37°C in a humid 
atmosphere;  HBSS was flooded under  the slides  and  incubation was  continued for  1 hr. 
Guinea pig complement  (Baltimore Biological Laboratories,  Baltimore,  Md.),  diluted  N0 
or 1/50 in 0.85% NaC1 buffered at pH 7.4 with 0.01 M phosphates and containing 5 X  10  -4 
Mg  ++ and 1.5 X  10  -4 M Ca  ++ (28) was added, and incubation was continued for another hour. 
PFC were counted at 7 X  magnification with indirect illumination. 
Indirect PFC ('yG and "yA immunoglobulin classes) were enumerated by two new methods 
in addition to the conventional method for indirect PFC  (29, 30).  In the blocked "yM PFC 
method, 0.05  ml of a  predetermined  optimal dilution of goat anti-mouse  g-chain antibody 
was  added  to  the  assay  tubes containing  agarose  in  Tris-MEM  and  indicator  erythro- 
cytes before the addition of the immune cell suspension (Fig. 1). The mixture was poured on 
agarose-coated microscope slides.  After 1 hr incubation, a predetermined optimal concentra- 
tion of polyvalent or monospecific rabbit anti-mouse globulin in HBSS was flooded under the 
slides; incubation was continued for 1 hr, the antiglobulin poured off, and the slides washed 
once gently with HBSS. Complement was then added and after 1 hr  incubation,  PFC  were 
counted. 
In the sequential PFC devdopment melhod, assay slides  containing indicator erythrocytes 
and immune cells in agarose in Tris-MEM were incubated as described for development of 
5'M PFC. Mter these PFC were counted (count 1), antiglobulin at optimal dilution or HBSS 
was flooded under the slides and incubation was continued as described for development of 
3'G PFC in the blocked 7M PFC method. No goat anti-g-antibody was ever added to these 
preparations.  After incubation with complement, total plaques were counted  (count 2). 
Cells recovered from culture dishes were counted with a Coulter Counter, Model B, with a 
100 g  aperture  (Coulter Electronics Inc., Hialeah, Fla.). The "I'M PFC/106  recovered cells 
were calculated from slides developed only with complement. 3'G and 'yA PFC/106 recovered 
cells in the blocked 7M PFC assay method were calculated directly from assay slides devel- 
oped by antiglobulin and  complement since the goat anti-g-antibody in the agarose layer 
prevented development of any 7M PFC. Control slides of indicator erythrocytes, goat anti- 
g-antibody, and immune cells in agarose incubated only with complement insured the com- 
plete blocking of all 3'M PFC. 
In the sequential PFC development method, counts 1 and 2 were converted to PFC/106 
recovered cells. The net increase in PFC or indirect PFC/106 recovered cells was calculated by 
subtraction of PFC/106 cells ( count 1) and additional 3'M PFC/106 cells developed by HBSS 
and complement from total PFC/106 cells (count 2).  Data presented are from  experiments 
with comparable cell recovery in all experimental groups and are representative  of data ob- 
tained in at least three separate expreriments. 
RESULTS 
Development o/the Blocked "yM PFC Assay Method.--Previous studies in our 
laboratory  had  not detected  significant primary 5'G PFC  responses  in  spleen 
cell cultures  of BALB/c  AnN  mice using conventional methods  of facilitation 
with  several  polyvalent  antiglobulins  (22).  These  polyvalent  antiglobulins 
are known  to inhibit "yM PFC  development; this inhibition must be corrected 
for in calculation of 7G  PFC  developed by such antiglobulins  (2, 29, 30). In the 
present  studies,  we  found  that  the  inhibition  of  7M  PFC  development  by 
polyvalent  antiglobulins  in  cultures  containing  only  "yM  PFC  varied  con- 
siderably from experiment to experiment and among mouse strains.  The mono- 400  IMMUNE  RESPONSES  IN  VITRO.  III 
specific  antiglobulins also variably inhibited ~,M PFC development, but to a 
far  lesser  degree.  Mter  taking  all  these  variables  into  account,  consistent 
primary ~,G PFC responses were recently detected in our culture system using 
the  conventional assay procedures  and  the  antiglobulin  reagents  described 
herein (31). However, the result obtained with this method showed considerable 
variability; therefore, a  more reliable method for detection of indirect PFC 
was developed which does not require application of correction factors to the 
data. 
Anti-TM antibody is known to inhibit development of 73~ PFC (2, 29, 30). 
We found that goat anti-/z-chain antisera prepared against MOPC-104E and 
absorbed with X-light chains reproducibly inhibited  development of all "y1Vi 
PFC when incorporated into the assay reagent mixture at final dilutions of 
1/,60o0-1/~600 depending on  the  antiserum. This  inhibition was almost com- 
pletely reversed by the addition of MOPC-104E myeloma protein at a concen- 
tration of 100 #g/ml; other myeloma proteins ('h, ")'2~, ")'2b, and 7A)  produced 
at most 10% reversal at 100/~g/ml. Unrelated proteins, such as bovine serum 
albumin,  had no effect on the blocking of ~,M  PFC development even at  1 
mg/ml. 
The incubation of assay slides containing the anti-#-antibody and immune 
cells  from 5-day cultures with polyvalent or  monospecific antiglobulins and 
complement reproducibly resulted in the development of significant numbers 
of plaques. The number of'),G or "),A PFC enumerated by the blocked ~?M PFC 
method was comparable to the number detected by the sequential PFC develop- 
ment method (Table II);  both  these methods compared favorably with the 
conventional assay method for detection of "yG or "),A PFC. In addition, the 
number of indirect PFC detected by developing PFC with anti-~,l  and anti- 
~'2~+2b together was similar to the sum of the number of ")'1 and ~'2~+2b PFC de- 
tected separately (Table II). 
Cultures of spleen cells from BALB/cAnN mice developed lower ~,G PFC 
responses to both SRBC and HRBC at all ages tested than did cultures of 
spleen cells from C57BL/6N mice; therefore, C57BL/6N mice were used for 
the remainder of the experiments reported. 
Specificity  of Plaques  Developed by A ntiglobulins  in  the  Blocked  ~IM  PFC 
Assay Method.-- The  specificity of antiglobulins for development of 7G  and 
TA plaques was demonstrated by absorption of antiglobulins with myeloma 
proteins and a competitive inhibition method. 
Monospecific and  polyvalent antiglobulins were  absorbed  with  myeloma 
proteins as indicated in Table III. Absorption was accomplished by adding 
sufficient  homologous  myeloma  proteins  to  precipitate  the  antibody  com- 
pletely; samples of antiserum with equal amounts of other myeloma proteins 
added served  as controls.  The number of plaques  developed by these  anti- 
globulins after absorption and removal of precipitates by centrifugation was PIERCE, JOHNSON,  GERSIION~ ASOI~SKY  401 
compared with the number developed by untreated  antiglobulin  at the same 
dilution and the per cent of inhibition of plaque development was determined. 
The  developing  activity of  the  monospecific  antiglobulins  (anti-'h,  anti- 
7A,  and  anti-72~+2b) was removed only by  absorption  with  the  homologous 
myeloma protein(s).  The  activity  of  the  polyvalent  anti-'rG was  markedly 
decreased after absorption with myeloma proteins of the "rG class; about 20% 
TABLE II 
Comparison  of the Blocked "yM PFC, Sequential  PFC Development,  and Conventional  Methods 
.for Enumeration of TG and "),A PFC 
Antiglobulins  used  to develop 
plaques 
PFC/10~ recovered cells 
Blocked~MPFCmethod  Conventional  method 
Exp.  1  Exp. 2  Exp. 2 
Anti-3'l  606  377  356 
Anti-72a+~b  303  309  259 
Anti-'yt +  anti-~'2a+2b  947 (909)*  656 (686)  578 (601) 
Anti-5'A  306  271  234 
Sequential  PFC Development Method 
Total increase  in PFC/10  6 cells 
(Count 2--count 1) 
Net increase  (TG or "VA PFC) 
PFC/10 6 cells:~ 
Exp. 1  Exp.  2  Exp. 1  Exp. 2 
HBSS  70  33  --  -- 
Anti-3'1  698  397  628  364 
Anti-'y~-2b  407  339  337  306 
Anti-5'A  400  337  330  304 
Immune cells  were from S-day stimulated cultures of C57BL/6N spleen cells; ")'M  PFC/106 
recovered cells were Exp. 1, 2235; Exp. 2, 1358. 
* Numbers in parentheses are the sums of PFC/106 cells from the separate assays with 
anti-3q and anti-')'2a+2b. 
:~ Number of additional "yM PFC appearing after incubation with HBSS and complement 
have been subtracted from the total increase in PFC/106 ceUs to obtain the net increase due 
to PFC developed by antiglobulin and complement. 
reduction in activity was also detected after absorption  with "i'M or "yA mye- 
loma proteins  (Table III). Results using both the blocked ~M  PFC  and se- 
quential  PFC  development methods were comparable (Table III). However, 
a word of caution must be raised with regard to the blocked ~/M PFC method 
when antiglobulins to which myeloma proteins have been added either for the 
purpose of  absorption  or  competitive inhibition  of  activity  are used  in  this 
assay  method.  ~M  myeloma  proteins,  or  reagents  contaminated  with  7M 
protein  not  detectable  by  other  methods,  may  cause  some  reversal  of  the 
blocking  of  "i'M  PFC  development  by  the anti-/z-serum. This reversal of 
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to which myeloma proteins had been added. 3'1,  3"2a+2h, and 3"A myeloma proteins 
caused less  than  10% reversal at concentrations of 100 gg/ml. "rM myeloma 
protein,  however, produced almost 95 %  reversal at  100 gg/ml, but less  than 
10%  reversal  at  10 #g/ml.  Therefore,  the  degree  of reversal  for  each  anti- 
globulin reagent to which myeloma proteins have been added must be deter- 
mined on an  immune cell  suspension  containing only 3`M PFC  (spleen  cells 
TABLE III 
Inhibition of 7G- and 7A-Plaque Devdopment by Absorption of Antiglobulins with Myeloma 
Proteins 
An tiglobulin  Myeloma protein 
absorbed with 
Average per cent inhibition of plaque 
development* 
Blocked 2zM PFC  Sequential PFC 
method  development method 
Anti-71 
Anti-72a+2b 
71  72  81 
72a+2b  4  2 
7M  2  1 
7A  5  3 
71  8  6 
7~+~b  81  89 
7M  0  0 
7A  0  0 
Anti-yA  71 +  3%+2b +  3'M  0  0 
7A  97  95 
Anti-7G (Polyvalent)  "Y1 A- T2a+2b  93  90 
"I'M  20  26 
7A  17  13 
* The values represent averages from at  least four separate experiments with different 
C57BL/6N immune cell suspensions from 5-day stimulated cultures using the absorbed anti- 
globulins at the same dilutions as the control, unabsorbed antiglobulins. The method used 
for absorption is presented in the text. 
from a 3 day stimulated culture)  on the same day that the reagent is used in 
assays on cell suspensions containing 3`G or 3'A PFC. Only in this manner can 
an accurate evaluation of the effects of proteins on the activity of antiglobulin 
reagents in the blocked 3'M PFC method be made.  This correction has been 
applied to the data obtained with the blocked ~/M PFC method in Table II[. 
Competitive inhibition of antiglobulin activity with myeloma proteins also 
demonstrated specificity. Myeloma proteins at a final concentration of 100-0.1 
#g/ml were incubated with optimal dilutions of the antiglobulins at 37°C for 
1 hr with periodic agitation. The activity of these preparations in developing 
indirect plaques was compared with untreated antiglobulins and the per cent of PIERCE~  JOHNSON,  GERSHON,  ASOFSKY  403 
inhibition  of  indirect  PFC  development  for  each  myeloma  protein  at  each 
concentration  was  calculated.  Significant  inhibition  of  activity  of  any  anti- 
globulin was achieved only with the homologous myeloma protein(s) (Table IV). 
Homologous  myeloma  proteins  inhibited  facilitation  almost  completely  at 
concentrations of 10/zg/ml. By contrast, other myeloma proteins produced at 
most 20 %  inhibition at concentrations of 100/zg/ml.  Corrections were applied 
TABLE IV 
Competitive Inhibition  of 3"G- and 3"A-Plaque Devdopment by Mydoma Proteins 
Antiglobulin  Myeloma protein 
Average per cent inhibition at 
concentration of myeloma protein (/~g/ml)* 
100  10  1  0.i 
Anti-3"l  3"1  96 (97)$  87  57  39 
3'~+2b  6 (3)  4  2  1 
3"M  8 (7)  3  3  0 
3"A  7 (3)  6  0  0 
Anti-3"2~-2b  3"2a+~b  100 (100)  98  89  67 
3"1  20 (17)  0  0  0 
7M  21 (23)  9  3  2 
3"A  13 (17)  11  2  0 
Anti-3"A  3"A  100 (98)  97  94  78 
3"1  0 (2)  2  3  3 
3'2a+2b  2 (2)  1  4  2 
3"M  5 (2)  2  3  3 
Anti-3"G  3'1 +  3"2a+2b  100 (98)  98  100  85 
3"M  11 (7)  3  3  1 
3"A  7 (3)  2  1  1 
* The values represent the averages from at least four separate experiments with different 
C57BL/6N immune cell suspensions from 5-day stimulated cultures at each myeloma protein 
concentration.  Details of the procedure and calculations are in the text. 
:~ Values in parentheses are averages from three separate experiments using the sequential 
PFC-development  method. 
for reversal of blocking of 3'M PFC in all experiments at each concentration of 
myeloma protein.  This was  especially important  when 3'M myeloma protein 
was  the  added  protein;  the  data  with  the  100  /zg/ml  concentration  of this 
myeloma protein  were  at best  an  approximation  since  blocking of 3'M PFC 
was completely reversed at this concentration.  Confirmation of all data in the 
competitive  inhibition  test  with  the  100/zg/ml  concentrations  was  obtained 
using the sequential PFC development method with immune cell concentrations 
that gave accurately countable numbers of PFC  per slide  (Table IV). 
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and absorbed with SRBC and mouse spleen cells,  at the same dilution as the 
rabbit  antiglobulins,  should  be  adequate.  However,  several  "normal  rabbit 
sera" developed indirect PFC.  Some of these sera consistently developed as 
many or more PFC than did optimal dilutions of anti-3,G, anti-~l, or anti-q,2~+2b. 
This  developing activity was  not  competitively inhibited  by  100  ~g/ml  of 
any myeloma protein. Furthermore, the addition of q¢1 or 3'2a+2b myeloma pro- 
teins  in  amounts  exceeding  that  required  to  absorb  activity  from  specific 
antiglobulins did not significantly reduce activity in  the  normal  rabbit  sera. 
Only  absorption  with  antigen-antibody complexes significantly reduced  the 
developing capacity of these sera; activity of the monospecific and polyvalent 
anti~I'G sera were unaffected by absorption with the same antigen-antibody 
complexes. Data similar to those obtained with the blocked 3'M PFC method 
were  also  obtained with  the  sequential  PFC  development method. 
It is uncertain whether this facilitating activity of some normal rabbit sera 
is due to a rheumatoid-like factor (32, 33) or some other artifact. This observa- 
tion  has merited a  more detailed separate study? It is  clear,  however,  that 
antiglobulins with nonspecific facilitating activity as found in  normal rabbit 
sera and some unabsorbed polyvalent anti-~/G sera must  be sought out  and 
eliminated from routine use.  Monospecific and absorbed polyvalent antiglob- 
ulins probably lack this abnormal reactivity since during their purification the 
immune complexes formed in  the reaction mixture removed the serum  com- 
ponents mediating the nonspecific facilitating activity. 
Culture Variables Affecting 3tM, ~G, and "yA PFC Responses.--As  indicated 
above,  C57BL/6N  mice  consistently developed higher  PFC  responses  than 
BALB/cAnN mice; responsiveness among other inbred mouse strains has not 
yet been fully investigated. No difference was found in the "I'M, 3'G, and ~,A 
PFC  responses  of  C57BL/6N  males  and  females.  SRBC  and  HRBC  both 
stimulated adequate 3'M, ~/G, and ~A PFC responses in cultures of C57BL/6N 
spleen  cells.  Since adequate  numbers  of PFC  representing  all  the  immuno- 
globulin  classes  were  detected with  the  culture  conditions  described above, 
modifications of these conditions were not made. 
Optimal  spleen cell concentration for development of maximal 5-day 3'M, 
~'G, and ~A  PFC responses was consistently between 15 and 8.5  )< 106 spleen 
cells/culture dish. In subsequent experiments, the spleen cell concentration was 
adjusted as closely as possible to 10 )<  106 cells/culture. The plot of the log of 
the 3'M or TG PFC response per dish against the log of the number of spleen 
cells initially cultured as the spleen cell concentration was varied from 25  to 
0.5  )<  106 cells/dish produced a regression line with a slope approximately 2.5 
over the linear portion of the plot. Earlier,  a  similar analysis of the ~/M re- 
sponse alone produced a regression line with a similar slope; it was suggested 
2 Pierce, C. W., B. Benacerraf, and R. Asofsky. Development of mouse indirect hemolytic 
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that interactions among three cell types were required for development of that 
response (34). 
Optimal antigen dose for stimulation of maximum "yM PFC  responses was 
about  1  X  107  red blood cells (RBC)/culture;  however, maximal3'G PFC  re- 
sponses  developed  consistently in cultures  stimulated with 106  RBC/culture 
(Table V),  Optimum 3'A responses  were  also  obtained with  106  RBC  (data 
TABLE V 
Effect of Mouse Age and Antigen Dose on 5-Day Primary ~/M and 3/G PFC Responses In Vitro 
Culture Variables: 
1.2 X  10  7 spleen cells/culture 
Mouse age  SRBC dose 
PFC/10 6 recovered cells 
Exp.  I  Exp.  2 
7M  "YG  "YM  7G 
months 
2  l0  s  786  149  942  243 
107  749  147  939  318 
106  690  340  835  395 
105  609  221  260  162 
0  48  6  29  0 
108  1346  427  1122  347 
107  1201  481  1474  351 
106  1066  528  1008  475 
105  495  275  474  458 
0  50  3  171  5 
10  s  832  177  1466  273 
107  837  191  1946  249 
106  665  235  1059  296 
105  309  138  640  130 
0  29  7  60  8 
108  715  220  661  101 
107  889  271  859  153 
106  686  350  688  373 
105  401  121  290  97 
0  111  2  30  4 
not  shown).  RBC  used  within  2  wk  after  collection stimulated  consistently 
reproducible responses in all immunoglobulin classes; RBC used after 14 days 
storage stimulated lower and more varied responses and were more fragile in 
the assay system. Subsequent experiments used RBC less than 14 days old at 
3-7  X  10 6 RBC/culture. Maximal 7M and ~G responses developed in cultures 
of spleens from mice 4-6 months old; however, responses in spleen cell cultures 
from mice as young as 2 months or as old as 9  months were adequate for the 
study of cellular events in the development of either'gM or 3'G responses (Table 406  IMMUNE  RESPONSES  IN  VITRO.  III 
V).  Responses  in  unstimulated  cultures  were  not  consistently  increased  in 
elderly mice. The optimal RBC doses for stimulation of maximal ~M and "yG 
responses did not vary with mouse age. 
Kinetics of Primary "yM, "vG, and "yA PFC Responses  In  Vitro.--The  PFC 
responses of cells representing major immunoglobulin classes were determined 
daily in  cultures of spleen cells incubated  with  or without  SRBC.  After  a  1 
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Fla. 2.  Kinetics of appearance of 3'M, 7G (polyvalent), and immunoglobulin  class-specific 
71, 3'2~+2b, and 3'A PFC in cultures of mouse spleen cells incubated with (closed figures) or 
without (open figures) SRBC. Daily cell recoveries in stimulated and unstimulated cultures 
were comparable. Data is from a representative experiment. 
day lag period,  the number of 3'M PFC  increased  exponentially from back- 
ground levels, about three PFC/10 ~ spleen cells,  to about 1000  PFC/10 ~ cells 
on day 4  in stimulated  cultures.  On  day 5,  only a  slight  decrease from this 
maximum was detected,  but thereafter 3'M  PFC  decreased  steadily  (Fig.  2). 
An  increase  in "y.¥[ PFC  against  SRBC  was  detected  also  in  unstimulated 
cultures;  this response reached a  maximum on days 4-5  and was always less 
than l0 % of the response in stimulated cultures. Similar background responses 
have been regularly detected by other investigators and are most likely due to 
antigens cross-reactive with SRB C antigens present in fetal bovine serum (21). 
PFC responses of cells representing 7G and ~A immunoglobulin classes pre- PIERCE, JOHNSON,  GERSHON,  ASOFSKY  407 
sented a  definite contrast. No significant increase from background levels of 
0.1-0.3 PFC/106 spleen cells was detected during the first 3 days of culture. 
Thereafter, a rapid exponential increase to maximum numbers on days 5 or 6 
was observed for 71, 72~+2b, and 7A PFC responses in stimulated cultures. After 
day 6,  all responses decreased quite sharply; all attempts to date to prolong 
these  responses beyond day  8  have failed.  It  is  significant to  note that 71, 
"Y2~+2b, and 7A PFC increase in numbers in parallel. ~1 and 72a+2b PFC/106 cells 
were about equal in numbers, whereas 7A PFC were always somewhat lower. 
The PFC responses developed by polyvalent anfi-TG were representative of the 
71 and'h~+2b responses; this antiglobulin reagent is free of nonspecific facilitating 
activity and  has been used  in  subsequent  experiments to conserve valuable 
monospecific antiglobulins. 7G  and 7A  PFC  also  increased in  unstimulated 
cultures, reaching numbers no greater than 10 % of the responses in stimulated 
cultures.  These background  responses  usually  reached maximums  on  day  6 
and declined very sharply by day 7. 
At no time during the 7 day incubation of stimulated cultures were~/M PFC 
of low hemolytic efficiency detected despite use of assay conditions and rabbit 
anti-TM antiglobulin known to develop indirect 7M PFC against SRBC in vivo 
(5) and in other immune systems (35, 36). In the remainder of this communica- 
tion we will present data comparing the effects of anti-erythrocyte antibody on 
the 7M and 7G PFC responses to evaluate the role of antigen in the induction 
of antibody production. 
Suppression of Primary "),M and 7G PFC Responses by Anti-SRBC Antibody. 
--Previous studies  had indicated that  antibody suppresses the 7M  PFC  re- 
sponse in vitro by neutralizing the effective antigenic stimulus at the macro- 
phage-dependent phase of the response (37). A rabbit antiserum against SRBC 
was  chosen for suppression of immune responses in the present  experiments 
since mouse  antibodies  produced  "false hemolytic plaques"  in  the  assay  of 
indirect PFC. 
To investigate the effect of antibody concentration on suppression of the ~,M 
and 7G PFC responses, spleen cells were incubated with 3  X  106 SRBC and 
3 X  10  ~ HRBC, and 0.05 ml of 10-fold dilutions of rabbit anti-SRBC with an 
initial hemagglutinin titer of 1/~o00. Antibody concentration (Fig. 3) was the 
reciprocal of the  titer in the culture dish.  High  concentrations of antibody, 
4  X  10  ° and 4  X  10  -I, caused marked suppression of both 7M and 7G PFC 
responses to SRBC, but had no effect on PFC responses to HRBC. As the con- 
centration of antibody was decreased, the degree of suppression decreased. At 
any given antibody concentration, the degree of suppression of 7G PFC was 
always greater than the suppression of 7M  PFC.  Antibody did not suppress 
the development of background 7M and 7G PFC (Fig. 3) ; this has been verified 
for all  concentrations of  antibody used  in  the  present  experiments.  Similar 
suppression of ~/M and 7G PFC to HRBC has been obtained with rabbit anti- 408  IMMUNE  RESPONSES  IN  VITRO.  III 
HRBC;  in  these  experiments  the  responses  to  SRBC  were  unaffected.  The 
observation that responses to HRBC were unaffected by anti-SRBC  showed 
that suppression of the responses to SRBC was specific and not due to toxicity 
of the antibody for the cultures. 
As was shown previously for ~'M responses alone (37),  suppressive activity 
of  the  anti-SRBC  was  also  demonstrated  with  antigen-antibody  complexes 
prepared with large amounts of antibody. Both 3'M and ~?G PFC responses to a 
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FIG. 3.  Effect of concentration of anti-SRBC on the suppression of primary 3~M and "yG 
PFC responses to SRBC. Cell recoveries in experimental groups were comparable; data is 
from a representative experiment. 
complex containing 107 SRBC prepared with an antibody concentration  of 4 X 
10  -~  were  suppressed  to almost  the  same degree as  responses  in  cultures  to 
which  antigen and antibody were added  separately. Suppressive activity was 
removed from the rabbit anti-SRBC  during  preparation  of the complexes as 
demonstrated by reduced suppressive capacity of the supernate from the com- 
plexes. HRBC did not remove suppressive activity from the anti-SRBC when 
substituted for SRBC in the preparation of complexes. 
Previous  studies  indicated  that  increasing  the  antigen  dose  overcame the 
suppressive  effects  of  antibody,  further  suggesting  that  the  mechanism  by 
which  antibody  suppressed immune  responses  was  by neutralization  of  the 
effective antigenic stimulus (37,  38). PIERCE,  JOHNSON,  GERSHON,  ASOFSK¥  409 
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At a  dose of 105 SRBC, ~M and q,G PFC responses were suppressed to back- 
ground levels by anti-SRBC  (Fig. 4  a).  As the SRBC dose was increased,  the 
degree of suppression of both q,M and ~'G responses decreased; at a dose of l0  s 
SRBC, suppression of both responses was completely abrogated (Fig. 4 a, 4 b). 
Further,  it is significant that  at  all  SRBC  doses  the degree of suppression  of 
the q'G  response  again  was  always  greater  than  the  suppression  of  the q,M 
response (Fig. 4 b). 
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FIG. 4.  Abrogation  of anti-SRBC-mediated  suppression  of primary 7M  and 7 G PFC 
responses to SRBC by increased SRBC concentration.  (a) Raw data from a representative 
experiment illustrating  the SRBC dose-PFC response relationship  for primary ~/M and q'G 
responses and the effect of anti-SRBC  on these relationships.  (b) Data are presented  as per 
cent  of control responses (responses in cultures  to which no antibody was added)  that de- 
veloped in antibody-treated  cultures at each SRBC concentration.  These data clearly depict 
the greater sensitivity of the "yG response to antibody at each SRBC  dose. Data are pooled 
from three experiments. 
The greater susceptibility of q,G responses to the suppressive effects of anti- 
body was further demonstrated  in experiments  where antibody was added  at 
24-hr intervals after initiation of the cultures (Fig. 5). q,M PFC responses were 
almost completely suppressed by antibody added at the initiation of the cultures 
or 24 hr later.  However, antibody added at 48 hr or later had little or no sup- 
pressive  effect.  In  contrast,  considerable  suppression  of ~/G  PFC  responses 
was obtained when antibody was added  during  the first 48  hr  of incubation. 
However,  at  72 hr and thereafter  little or no suppression of ~/G responses was 
obtained by the addition of anti-SRBC. 410  IMMUNE  RESPONSES  IN  VITRO. III 
Spleen cells exposed to an anti-SRBC concentration of 4 )< 10  ° in the absence 
of SRBC for 24 hr and then washed repeatedly before the addition of 3  X  10 ~ 
SRBC and HRBC had suppressed ~M and ~G PFC responses to SRBC,  but 
not  to HRBC. "yG responses were more affected than ?M  responses and  the 
degree of suppression of both responses was less than  if the 4  X  10  ° concen- 
tration of anti-SRBC was present throughout  the incubation period.  Further, 
if an additional 10  T SRBC were added 6 hr after the initial SRBC, the suppres- 
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Fro. 5.  Suppression of primary ~'M and "1,13 PFC responses to SRBC by anti-SRBC added 
at 24-hr intervals after initiation of cultures. 
sion of both "i'M and ?G PFC responses was abrogated. These data indicated 
that antibody may also act directly on one of the interacting cell types required 
for generation of ?M and ~,G PFC responses. 
Mouse  spleen  cells  can  be  conveniently  separated  into  adherent  (mostly 
macrophages)  and  nonadherent  (mostly  lymphocytes)  populations  (39-41); 
both populations are required for generation of ?M and ?G PFC responses in 
vitro  ~ (42). Experiments identical in design and methodology to those reported 
previously (37)  have confirmed our original observations for "yM response and 
extended the observations to the "yG PFC responses. Incubation of separated 
adherent  cells  with  anti-SRBC  antibody  caused  suppression  of  the ?M  and 
3 Pierce, C. W., and B. M. Johnson. Immune responses in vitro. IV. Cell interactions in the 
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7G PFC responses to SRBC, but not to HRBC in cultures reconstituted with 
untreated nonadherent cells.  Incubation of nonadherent cells,  which contain 
antibody-forming cell  precursors  (40),  with  antibody did not  produce  sup- 
pression of either the 7M or ~/G PFC  responses. As in other experiments with 
anti-SRBC, the degree of suppression of the "}'G responses was greater than the 
degree of suppression  of the ~,M response.  These data confirm  our  original 
findings that  antibody suppresses  the immune response  by neutralizing the 
effective antigenic stimulus at the level of the macrophage. 
DISCUSSION 
We have described the development of ~1, ~'2~+2s, and vA as well as ~,M PFC 
responses in cultures of mouse spleen cells stimulated in vitro with heterologous 
erythrocytes. A new procedure for detecting indirect (~,G and 7A) PFC makes 
analysis of these immunoglobulin class-specific  responses  possible.  This new 
method makes use of the fact that development of direct (~/M) PFC can be 
completely inhibited by incorporation of appropriate  amounts of a  suitable 
anti-IgM specific  antibody into the agarose-indicator erythrocyte-assay mix- 
ture. The technique offers several advantages over the conventional methods 
(1, 2, 5, 10, 11, 29, 30) for assaying indirect PFC. First, the indirect PFC can 
be  directly enumerated from the assay slides.  In  conventional procedures  a 
correction must  be  made for  the  frequently observed  suppressive  effect of 
facilitating  antiglobulins  on  development  of  ~/M  PFC.  Second,  responses 
studied with this method are more reproducible than with conventional pro- 
cedures.  Finally, the new procedure is rapid;  it is certainly less cumbersome 
than the sequential PFC development method which requires two periods of 
incubation and two separate PFC counts. The number of indirect PFC deter- 
mined by this latter procedure and the number determined by the new blocked 
~,TN[ PFC method were in very close agreement. The sequential PFC develop- 
ment method was extremely useful, however, in confirming the results of the 
specificity controls. 
Absorption  and  competitive inhibition controls  established  the  specificity 
of both  blocking  (anti-k)  and facilitating (anti-~/G,  anti-~,l,  anti-'h~-2b,  and 
anti-~,A)  reagents. In general, homologous myeloma proteins were more than 
10 times as efficient in blocking a specific antiglobulin activity than were non- 
homologous myeloma proteins. The small amount of blocking obtained with 
heterologous  myeloma proteins  can  be  readily  explained  by  the  inevitable 
small contamination of purified myeloma proteins with normal immunoglob- 
ulins. The absolute requirement for such specificity controls was demonstrated 
by the observation that certain normal rabbit sera developed indirect PFC in 
all assay procedures  employed. The facilitating activity of these sera  could 
neither be blocked nor absorbed with myeloma proteins, but was removed only 
by immune complexes as has been discussed above. 
A  PFC  response  specific  for  each  major  class  of  mouse  immunoglobulin 412  IMMUNE  RESPONSES  IN  VITRO.  III 
developed in vitro. Although the antiglobulin specific  for 3'2a+2b did not  dis- 
tinguish between these individual immunoglobulins, it has been shown else- 
where  (5)  that this antiglobulin is only partially blocked by either  class of 
myeloma protein alone. Reagents specific for the "Y8 immunoglobulin class were 
not available during this study (43). 
In general, tissue culture conditions which supported adequate 3'M responses 
also supported 3'G and ~/A responses in vitro.  Concentrations of spleen cells 
and ages of mice from which the cells were obtained that produced optimum 
~M responses also produced optimum 3"G responses. As has been observed for 
~M responses  (21,  22),  a  low level of 3'G response was seen in unstimulated 
cultures. Finally, both "yM and "yG PFC responses were specifically suppressed 
by inclusion in the cultures of appropriate amounts of specific anti-erythrocyte 
antibody. It was shown that this inhibition was the result of neutralization of 
the  effective antigenic stimulus  at  the macrophage-dependent phase  of the 
response.  This  has  been  estabhshed  previously in  this  laboratory  (37)  and 
suggested by others (38) only for ~/M responses in vitro, and is consistent with 
results of the suppressive effects of antibody in vivo (44--46). 
A detailed study of the kinetics of appearance of "yG and "yA PFC showed 
that'y1, 3% and 3'A PFC appeared 1-2 days later than did 3'M PFC and reached 
a peak 1 day later. The 3'1 and 72~+2b responses were somewhat greater than 3'A 
responses,  but  all responses  showed identical kinetics.  These  differences in 
rates of appearance of "),M and 3'G PFC  are similar to those observed after 
immunization in vivo (1, 2, 5). 
A greater sensitivity of the 3'G PFC response to antibody was revealed in two 
ways. First,  any given dose of antibody had  a  proportionally greater  effect 
on the TG than on the "I'M response. Second, the ~G response could be inhibited 
by antibody added up to 48 hr after stimulation; in the case of the ~/M response, 
antibody had to be added before 24 hr after stimulation to achieve complete 
suppression. It has been shown that in the development of the 3'M PFC re- 
sponse,  the first 24  hr is the interval during which critical interactions take 
place among the various types of lymphoid cells,  macrophages,  and antigen 
(41). The finding that 3'G responses are susceptible to suppressive antibody for 
48 hr suggests that these responses may require more prolonged interactions 
among macrophages, antigen, and lymphoid cells for their development (42). 
The investigations of these cell interactions in the development of the primary 
~G response will be described in a later communication.  ~ 
A small but consistent difference was seen in the present experiments in the 
erythrocyte doses which stimulated maximum 3'M and "yG responses. Doses of 
antigen which produced optimum 3'M responses were of an order of magnitude 
higher than those that produced optimum 3'G responses. With higher erythro- 
cyte doses, ~G responses were suboptimal. At no erythrocyte dose was the 3'G 
response equal to the 3'M response. Indeed, 3'M responses equal to optimal "yG 
responses were usually obtained with low doses of antigen (see Table V).  These PIERCE,  JOHNSON, GERSHON, ASOFSKY  413 
findings may be related  to the greater observed sensitivity of the ~'G  PFC 
responses  to  anti-erythrocyte antibody  added  to  the  cultures  as  discussed 
previously. It is known that 3'M  antibody may have an enhancing effect on 
immune response in vivo (46). It must be remembered, however, that 3'M anti- 
body in vivo is almost all confined to the circulating blood, and in the mouse 
is catabolized at a very rapid rate (47). In vitro, a greater accumulation of 3'M 
antibody in  intimate contact with  reactive and  differentiating cells is  to be 
expected, and it may, in these circumstances, play an important role in the 
development and regulation of ~'G PFC responses. 
SUMMARY 
We have demonstrated for the first time that mouse spleen ceils stimulated 
in  vitro  with  heterologous  erythrocytes  developed  immunoglobulin  class- 
specific'yM, "h, "Y2~+2b, and 5'A plaque-forming cell (PFC) responses. A modifica- 
tion of the hemolytic plaque technique, the addition of goat anti-mouse #-chain 
antibody to the assay preparation, specifically prevented development of all 
"yM PFC and enabled accurate and reproducible enumeration of immunoglob- 
ulin  class-specific PFC  after  treatment  with  appropriate  monospecific anti- 
globulins  and  complement.  Culture  conditions,  with  regard  to medium,  at- 
mosphere, agitation, and spleen cell densities, were similar to those previously 
shown to support only "/M PFC responses. Evaluation of the kinetics of ap- 
pearance of PFC showed that 5'M PFC reached maximum numbers on days 
4-5; the magnitude of this response was 3-10 times greater than 71, ~2a+2b, or 
~/A PFC which reached maximum numbers on days 5-6. Optimal erythrocyte 
antigen dose for ~'M  PFC  responses was  107/culture,  whereas  a  dose  of  106 
erythrocytes/culture consistently stimulated  optimal ~1,  "Y2a+2b, or "yA  PFC 
responses.  Investigations of the  effects of anti-erythrocyte antibody on ~/M 
and ~/G PFC responses indicated that antibody suppressed these responses by 
neutralizing  the  effective  antigenic  stimulus  at  the  macrophage-dependent 
phase of the response. At the same antibody concentration, "yG PFC responses 
were more effectively suppressed  than ~M  PFC  responses.  Further,  "yG re- 
sponses could be almost completely suppressed by antibody as long as 48 hr 
after initiation  of cultures,  whereas-yM  PFC  responses could only be com- 
pletely suppressed during the first 24 hr. These results were discusssed in terms 
of the role of antigen in the stimulation ~/M and ~/G antibody. 
The authors  thank Dr. Baruj Benacerraf for his advice and encouragement  during  these 
experiments and preparation  of the manscript. 
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